NCT04500132View on ClinicalTrials.gov

To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

May 28, 2020

Primary Completion Date

February 4, 2021

Study Completion Date

February 15, 2021

Conditions
COVID-19
Interventions
DRUG

EC-18

EC-18 QD

DRUG

Placebo EC-18

Placebo EC-18 QD

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Cheongju-si

Sponsors
All Listed Sponsors
lead

Enzychem Lifesciences Corporation

INDUSTRY